CRISPR pioneer Jennifer Doudna turns lab into coronavirus test center

| | April 2, 2020
igi covid testing px
Dirk Hockemeyer, an associate professor of molecular and cell biology at UC Berkeley, testing steps in the pipeline that will be used to analyze patient samples. When testing actual patient swabs, he will don full PPE. Credit: Max & Jules Photography
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

A team of academic and industry researchers led by Jennifer Doudna, the researcher best known for her role in the discovery of the gene editing technology called CRISPR, has turned a 2,500-square-foot scientific laboratory into a facility for running medical tests to detect the novel coronavirus that causes Covid-19.

The laboratory, which plans to serve hospitals in the San Francisco Bay Area, says it will be able to process more than 1,000 patient samples a day with a 24-hour turnaround, Doudna announced [March 29]. The lab will ramp up to processing 3,000 samples a day if necessary.

The effort is one more sign of the desperation in major metropolitan areas to ramp up testing for the coronavirus, called SARS-CoV-2. Two weeks ago, the U.S. had only processed 42,000 tests over the course of the coronavirus pandemic, according to the Covid Tracking Project, a volunteer effort. As of this week, the total number of test results returned has risen to nearly 900,000.

Related article:  Cases of COVID-19 reinfection reported. Does that shatter immunity hopes?

Doudna’s effort isn’t the first in academia. The Broad Institute in Cambridge, Mass., began processing test results [March 26], and said it would be able to process 2,000 tests a day with a 12-hour turnaround.

Read the original post

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend